etidronic acid

acetodiphosphonic acid cublen HE-K 60 didronel IV oxy ethylidenediphosphonic acid (1- hydroxy-1-phosphono-ethyl)-phosphonic acid (1- hydroxy-1-phosphonoethyl)phosphonic acid (1- hydroxy-1,1-ethanediyl)bis(phosphonic acid) 1- hydroxyethane-1,1-bisphosphonic acid 1- hydroxyethane-1,1-diphosphonic acid (1- hydroxyethane-1,1-diyl)bis(phosphonic acid) (1- hydroxyethane-1,1-diyl)diphosphonic acid 1- hydroxyethane-1,1,-diphosphonic acid 1- hydroxyethanediphosphonic acid (1- hydroxyethylene)diphosphonic acid 1- hydroxyethylidene-1,1-diphosphonic acid 1- hydroxyethylidene-1,1-diphosphonicacid (1- hydroxyethylidene)bis(phosphonic acid) (1- hydroxyethylidene)bisphonic acid (1- hydroxyethylidene)bisphosphonic acid (1- hydroxyethylidene)diphoshonic acid hydroxyethylidene)diphosphonic acid (1- hydroxyethylidene)diphosphonic acid 1- hydroxyethylidenediphosphonic acid phosphonic acid, (1-hydroxyethylidene)bis- PubMed: Biosorption of heavy metal ions onto agricultural residues buckwheat hulls functionalized with 1-hydroxylethylidenediphosphonic acid. PubMed: Intravenous zoledronic acid: what are the indications for male osteoporosis? PubMed: Effect of osteoporosis treatment on mortality: a meta-analysis. PubMed: Comparison of the effects of once-monthly versus once-daily risedronate in postmenopausal osteoporosis: a phase II, 6-month, multicenter, randomized, double-blind, active-controlled, dose-ranging study. PubMed: Risedronate dosing before breakfast compared with dosing later in the day in women with postmenopausal osteoporosis. PubMed: Compatibility of risedronate sodium tablets with food thickeners. PubMed: Paget disease of bone: therapeutic options. PubMed: Nonvertebral fracture risk reduction with nitrogen-containing bisphosphonates. PubMed: Effects of risedronate 5 mg/d on bone mineral density and bone turnover markers in late-postmenopausal women with osteopenia: a multinational, 24-month, randomized, double-blind, placebo-controlled, parallel-group, phase III trial. PubMed: Evaluation of 41calcium as a new approach to assess changes in bone metabolism: effect of a bisphosphonate intervention in postmenopausal women with low bone mass. PubMed: Effect of administration site in the gastrointestinal tract on bioavailability of poorly absorbed drugs taken after a meal. PubMed: Importance of calcium co-medication in bisphosphonate therapy of osteoporosis: an approach to improving correct intake and drug adherence. PubMed: Pharmaceutical care and community pharmacists' understanding of bisphosphonate dosing information. PubMed: Clinical trial of risedronate in Japanese volunteers: a study on the effects of timing of dosing on absorption. PubMed: An approach to postmenopausal osteoporosis treatment: a case study review. PubMed: Prevention and treatment of osteoporosis. PubMed: Bone density changes with once weekly risedronate in postmenopausal women. PubMed: Treatment of hypercalcemia of malignancy with bisphosphonates. PubMed: Food-drug interactions. PubMed: Risedronate: a new oral bisphosphonate. PubMed: Gender differences in osteoporosis treatment: a review of clinical research. PubMed: Timing of cyclical etidronate. PubMed: Prevention and treatment of osteoporosis. PubMed: The effect of dosing regimen on the pharmacokinetics of risedronate. PubMed: Evaluation of the effects of risedronate on hepatic microsomal drug metabolizing enzyme activities following administration to rats for 14 days: lack of an induction response. PubMed: Risedronate released for Paget's disease. PubMed: Bisphosphonates: preclinical aspects and use in osteoporosis. PubMed: Adverse effects of bisphosphonates. A comparative review. PubMed: Osteoporosis: pathophysiology, prevention, diagnosis, and treatment. PubMed: Etidronate for hypercalcemia of malignancy and osteoporosis. PubMed: Absorption of oral diphosphonate in normal subjects.